Research on heterocyclic compounds. IX - Heteroarylcarboxamides and acetamides: antiinflammatory and related pharmacological properties. 1980

E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo

A series of imidazo[1,2-a]pyrimidine-, imidazo[1,2-c]pyrimidine- and imidazo[1,2-b]pyridazinecarboxamides and acetamides were prepared and their antiinflammatory, analgesic, antipyretic and ulcerogenic activities were evaluated.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D005260 Female Females
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents

Related Publications

E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
August 1983, Il Farmaco; edizione scientifica,
E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
January 1990, Pharmacological research,
E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
November 1975, Il Farmaco; edizione scientifica,
E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
July 1989, Research communications in chemical pathology and pharmacology,
E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
June 1992, Farmaco (Societa chimica italiana : 1989),
E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
August 1968, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
December 1970, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
January 1954, Acta physiologica et pharmacologica Neerlandica,
E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
May 1993, Chemical & pharmaceutical bulletin,
E Abignente, and F Arena, and P De Caprariis, and G Montagnaro, and F Rossi, and E Lampa, and L Giordano, and C Vacca, and E Marmo
December 1957, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!